Data

COBRA-seq: Sensitive and Quantitative Methylome Profiling

Commonwealth Scientific and Industrial Research Organisation
Varinli, Hilal ; Stathan, Aaron ; Clark, Sue ; Molloy, Peter ; Ross, Jason
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.4225/08/5609BE3FBF228&rft.title=COBRA-seq: Sensitive and Quantitative Methylome Profiling&rft.identifier=https://doi.org/10.4225/08/5609BE3FBF228&rft.publisher=Commonwealth Scientific and Industrial Research Organisation&rft.description=We describe two versions of COBRA-seq: First, Genome-Wide COBRA (GW-COBRA) that uses PCR to exponentially amplify the sequencing library fragments after linker ligation. Second, Linear Amplification COBRA (LA-COBRA) that relies on T7 RNA polymerase-mediated transcription yielding many RNA transcripts of the library fragments generated in a linear manner which are subsequently converted to cDNA. The COBRA-seq library protocol is largely adapted to provide robust coverage of the human genome, however, all of the steps are applicable to both model and non-model organisms.Lineage: We prepared GW-COBRA and LA-COBRA sequencing libraries from the colon carcinoma (HCT116) cell line and analyzed the methylome with 100 bp single-end sequencing using Illumina HiSeq2000 chemistry. We also compared, in silico, the quantitative, qualitative and genome coverage specifications of COBRA-seq with other common DNA methylome technologies.&rft.creator=Varinli, Hilal &rft.creator=Stathan, Aaron &rft.creator=Clark, Sue &rft.creator=Molloy, Peter &rft.creator=Ross, Jason &rft.date=2015&rft.edition=v2&rft_rights=CSIRO Data Licence https://research.csiro.au/dap/licences/csiro-data-licence/&rft_rights=Data is accessible online and may be reused in accordance with licence conditions&rft_rights=All Rights (including copyright) CSIRO Australia 2015.&rft_subject=COBRA&rft_subject=DNA methylation&rft_subject=reduced representation&rft_subject=non CpG&rft_subject=non-model organism&rft_subject=restriction enzymes&rft_subject=next generation sequencing&rft_subject=enhancer&rft_subject=CHH&rft_subject=Medical biochemistry - nucleic acids&rft_subject=Medical biochemistry and metabolomics&rft_subject=BIOMEDICAL AND CLINICAL SCIENCES&rft.type=dataset&rft.language=English Access the data

Licence & Rights:

Other view details
Other

CSIRO Data Licence
https://research.csiro.au/dap/licences/csiro-data-licence/

Data is accessible online and may be reused in accordance with licence conditions

All Rights (including copyright) CSIRO Australia 2015.

Access:

Open view details

Accessible for free

Contact Information



Full description

We describe two versions of COBRA-seq: First, Genome-Wide COBRA (GW-COBRA) that uses PCR to exponentially amplify the sequencing library fragments after linker ligation. Second, Linear Amplification COBRA (LA-COBRA) that relies on T7 RNA polymerase-mediated transcription yielding many RNA transcripts of the library fragments generated in a linear manner which are subsequently converted to cDNA. The COBRA-seq library protocol is largely adapted to provide robust coverage of the human genome, however, all of the steps are applicable to both model and non-model organisms.



Lineage: We prepared GW-COBRA and LA-COBRA sequencing libraries from the colon carcinoma (HCT116) cell line and analyzed the methylome with 100 bp single-end sequencing using Illumina HiSeq2000 chemistry. We also compared, in silico, the quantitative, qualitative and genome coverage specifications of COBRA-seq with other common DNA methylome technologies.

Available: 2015-09-29

This dataset is part of a larger collection

Click to explore relationships graph